AAP was upgraded from Neutral to Outperform, Wedbush Morgan said. $51 price target. Positive channel checks mean that the company's gross margin could continue to grow.
AMSC was upgraded from Hold to Buy, Deutsche Bank said. $38 price target. Company should offer bullish near-term guidance and help the stock reverse its recent underperformance.
ARUN was downgraded from Outperform to Market Perform, BMO Capital Markets said. Stock is already up 30% year-to-date. $14 price target.
Coverage of CFR was started with a Market Perform rating, FBR Capital Markets said. $58 price target. Company is positioned well, but trades at a premium to its peers.
CHKP was initiated with an Equal-weight rating, Morgan Stanley said. Company is a strong operator, but lacks significant catalysts until 2011.
CPHD downgraded to Market Weight from Overweight. Still view Cepheid as a leader in molecular diagnostics, but hospital spending is weak, Thomas Weisel said. Price target raised to $20.
EV was downgraded to Market Perform, Wells Fargo said. Valuation call, as the stock has outperformed its peers since October.
GPN was upgraded to Outperform, Wells Fargo said. Risk/reward is more attractive, following the recent sell-off.
JBHT estimates were increased through 2012, Goldman Sachs said. Company is seeing better pricing trends. Neutral rating and new $40 price target.
JBHT was upgraded from Market Perform to Outperform, FBR Capital Markets said. $43 price target. Intermodal pricing cycle is likely bottoming.
OMC was upgraded from Hold to Buy, Deutsche Bank said. $46 price target. Stock is not yet pricing in the company's long-term stability and returns.
PDE was upgraded to Equal-weight, Morgan Stanley said. $40 price target. Deepwater fundamentals could improve over the next 6 months.
PGR upgraded to Neutral from Underperform. Positive on the fundamentals of the personal auto industry, Credit Suisse said. Price target jumped to $22 from $18. 2010 and 2011 EPS estimates set at $1.45 and $1.55, respectively.
RSG upgraded to Buy from Neutral as a resumption of industry volume growth heading into 2011 should drive shares higher, Bank of America/Merrill Lynch said. Price target raised to $35 from $28.
SY was downgraded from Buy to Hold, Jefferies said. $47 price target. Company is facing a transition year.
TEX was initiated with a Buy rating, Morgan Joseph said. $32 price target. Sale of the mining business leaves a very profitable core operation.
TIF was initiated with a Buy rating, Deutsche Bank said. $58 price target. Company can double its store base in the U.S., Europe and Asia.
UPS upgraded at Piper Jaffray. Rating raised to Overweight from Neutral. Price target raised to $79 from $64. 2010 EPS estimates raised to $3.15 from $2.79.
UPS estimates were increased through 2012, Goldman Sachs said. Company is seeing operating leverage through higher volumes. Buy rating and new $82 price target.
WCN downgraded to Neutrral from Buy on valuation, Bank of America/Merrill Lynch said. Price target raised $2 to $37.
ZION was upgraded from Neutral to Buy, Suntrust Robinson Humphrey said. $36 price target. Capital raise will not be as dilutive at current levels, which boosts potential normalized earnings.
Shares of ADTN now seen reaching $35, according to Citigroup. Company should benefit from broadband stimulus spending. Buy rating.
Caterpillar price target boosted at Credit Suisse
CAT price target surged to $82 from $70 as dealers are forecasting sales increases, Credit Suisse said. 2010 and 2011 EPS estimates raised to $3.25 and $4.50, respectively. Outperform rating.
CAT price target surged to $82 from $70 as dealers are forecasting sales increases, Credit Suisse said. 2010 and 2011 EPS estimates raised to $3.25 and $4.50, respectively. Outperform rating.
Shares of CSX now seen reaching $53, according to Goldman Sachs. Company is realizing higher gross margins. Sell rating.
Shares of GPS now seen reaching $32, according to FBR Capital Markets. Estimates also increased, because of international growth potential. Outperform rating.
GWW target was raised to $130, Oppenheimer said. Company raised guidance and the stock appears attractive, following a post-earnings sell-off. Outperform rating.
JNPR price target increased to $37 from $33. Robust 1Q10 in both carrier and enterprises, Barclays said. 2010 EPS estimate raised to $1.34, 2011 held at $1.63. Overweight rating.
PM price target raised to $60 from $55 after 1Q10 beat, Barclays said. 2010 and 2011 EPS estimates lifted to $3.25 and $5.10, respectively. Maintain Overweight rating.
Shares of JPM now seen reaching $50, according to UBS. Estimates also raised, because of a more favorable credit outlook. Neutral rating.
JPM estimates were raised through 2011, Goldman Sachs said. Company is seeing better sales and credit trends. Buy rating and $54 price target.
Shares of LLTC now seen reaching $35, according to Goldman Sachs. Estimates also boosted, to match the company's new sales guidance. Buy rating.
MRVL target was boosted to $26, Morgan Stanley said. Market is not giving credit for the company's non-HDD growth opportunities. Overweight rating.
NKE target was increased to $86, Citigroup said. Company will likely host an upbeat investor meeting in early May. Buy rating.
T 2010 and 2011 EPS estimates lowered to $1.93 and $2.33, respectively. Overall slowdown in the postpaid segment, Barclays said. Reiterate Equal Weight rating and $30 price target.
TSN price target increased to $23 from $20. Chicken margins quite good, Credit Suisse said. 2010 and 2011 EPS estimate both raised to $1.75. Outperform rating.
UPS price target surged to $78 from $67 in expectations of a strong first quarter, Barclays said. 2010 EPS estimate lifted to $3.35, 2011 set at $3.90. Overweight rating.
VIAB price target improved to $36 from $31 as ratings stabilize, Credit Suisse said. 2010 and 2011 EPS estimates maintained at $2.77 and $3.12, respectively. Neutral rating.
WBSN target was boosted to $30, Morgan Stanley said. Expanding product portfolio appears to be driving accelerated billings growth. Overweight rating.
Shares of YUM now seen reaching $45, Morgan Stanley said. Estimates also increased, as the company is seeing higher comp sales. Overweight rating.